Changes in Anti-Müllerian Hormone (AMH) throughout the life span: A population-based study of 1027 healthy males from birth (cord blood) to the age of 69 years

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 12, 2010, Pages 5357-5364

  Aksglaede, Lise ^a   Sorensen K ^a   Boas, M ^a   Mouritsen, A ^a   Hagen, C P ^a   Jensen, R B ^a   Petersen, J H ^a,b   Linneberg, A ^c   Andersson, A M ^a   Main, K M ^a   Skakkebaek N E ^a   Juul, A ^a  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; LUTEINIZING HORMONE; MUELLERIAN INHIBITING FACTOR; TESTOSTERONE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CIRCADIAN RHYTHM; DEVELOPMENTAL STAGE; FOLLITROPIN BLOOD LEVEL; FOLLOW UP; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; INFANCY; INFANT; LIFESPAN; LUTEINIZING HORMONE BLOOD LEVEL; MALE; NEWBORN; NORMAL HUMAN; ONTOGENY; PRESCHOOL CHILD; PRIORITY JOURNAL; PUBERTY; SCHOOL CHILD; TESTOSTERONE BLOOD LEVEL; UMBILICAL CORD BLOOD;

EID: 78650045339     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-1207     Document Type: Article

References (39)

1. Lee MM, Donahoe PK 1993 Mullerian inhibiting substance: a gonadal hormone with multiple functions. Endocr Rev 14:152-164
2. Josso N, Lamarre I, Picard JY, Berta P, Davies N, Morichon N, Peschanski M, Jeny R 1993 Anti-mullerian hormone in early human development. Early Hum Dev 33:91-99 (Pubitemid 23226525)
3. Rajpert-De Meyts E, Jørgensen N, Graem N, MüllerJ, Cate RL, Skakkebaek NE 1999 Expression of anti-Mullerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells. J Clin Endocrinol Metab 84:3836-3844 (Pubitemid 30645250)
4. Rey R, Lukas-Croisier C, Lasala C, Bedecarrás P 2003 AMH/MIS: what we know already about the gene, the protein and its regulation. Mol Cell Endocrinol 211:21-31
5. Teixeira J, Maheswaran S, Donahoe PK 2001 Mullerian inhibiting substance: an instructive developmental hormone with diagnostic and possible therapeutic applications. Endocr Rev 22:657-674 (Pubitemid 32955249)
6. Lee MM, Donahoe PK, Silverman BL, Hasegawa T, Hasegawa Y, Gustafson ML, Chang YC, MacLaughlin DT 1997 Measurements of serum mullerian inhibiting substance in the evaluation of children with nonpalpable gonads. N Engl J Med 336:1480-1486 (Pubitemid 27215162)
7. Sørensen K, Aksglaede L, Petersen JH, Juul A 2010 Recent changes in pubertal timing in healthy Danish boys: associations with body mass index. J Clin Endocrinol Metab 95:263-270
8. Boas M, Hegedüs L, Feldt-Rasmussen U, Skakkebaek NE, Hilsted L, Main KM 2009 Association of thyroid gland volume, serum insulin-like growth factor-I, and anthropometric variables in euthyroid prepubertal children. J Clin Endocrinol Metab 94:4031-4035
9. Thyssen JP, Linneberg A, Menné T, Nielsen NH, Johansen JD 2009 The prevalence and morbidity of sensitization to fragrance mix I in the general population. Br J Dermatol 161:95-101
10. Main KM, Toppari J, Suomi AM, Kaleva M, Chellakooty M, Schmidt IM, Virtanen HE, Boisen KA, Kai CM, Damgaard IN, Skakkebaek NE 2006 Larger testes and higher inhibin B levels in Finnish than in Danish newborn boys. J Clin Endocrinol Metab 91:2732-2737
11. Chellakooty M, Schmidt IM, Haavisto AM, Boisen KA, Damgaard IN, Mau C, Petersen JH, Juul A, Skakkebaek NE, Main KM 2003 Inhibin A, inhibin B, follicle-stimulating hormone, luteinizing hormone, estradiol, and sex hormone-binding globulin levels in 473 healthy infant girls. J Clin Endocrinol Metab 88:3515-3520
12. Marshall WA, Tanner JM 1970 Variations in the pattern of pubertal changes in boys. Arch Dis Child 45:13-23
13. Zachmann M, Prader A, Kind HP, Häfliger H, Budliger H 1974 Testicular volume during adolescence. Cross-sectional and longitudinal studies. Helv Paediatr Acta 29:61-72
14. Jensen RB, Vielwerth S, Larsen T, Greisen G, Veldhuis J, Juul A 2007 Pituitary-gonadal function in adolescent males born appropriate or small for gestational age with or without intrauterine growth restriction. J Clin Endocrinol Metab 92:1353-1357
15. Rigby RA, Stasinopoulos M 2005 Generalized additive models for location, scale and shape (with discussion). Appl Statist 54(Part 3):507-554
16. Andersson AM, Toppari J, Haavisto AM, Petersen JH, Simell T, Simell O, Skakkebaek NE 1998 Longitudinal reproductive hormone profiles in infants: peak of inhibin B levels in infant boys exceeds levels in adult men. J Clin Endocrinol Metab 83:675-681 (Pubitemid 28496556)
17. Grumbach MM 2005 A window of opportunity: the diagnosis of gonadotropin deficiency in the male infant. J Clin Endocrinol Metab 90:3122-3127
18. Rey R, al-Attar L, Louis F, Jaubert F, Barbet P, Nihoul- FékétéC, Chaussain JL, Josso N 1996 Testicular dysgenesis does not affect expression of anti-mullerian hormone by Sertoli cells in premeiotic seminiferous tubules. Am J Pathol 148:1689-1698
19. Boukari K, Meduri G, Brailly-Tabard S, Guibourdenche J, Ciampi ML, Massin N, Martinerie L, Picard JY, Rey R, LombèsM, Young J 2009 Lack of androgen receptor expression in Sertoli cells accounts for the absence of anti-Mullerian hormone repression during early human testis development. J Clin Endocrinol Metab 94:1818-1825
20. Lee MM, Donahoe PK, Hasegawa T, Silverman B, Crist GB, Best S, Hasegawa Y, Noto RA, Schoenfeld D, MacLaughlin DT 1996 Mullerian inhibiting substance in humans: normal levels from infancy to adulthood. J Clin Endocrinol Metab 81:571-576
21. Pasqualini T, Chemes H, Rivarla MA 1981 Testicular testosterone levels during puberty in cryptorchidism. Clin Endocrinol (Oxf) 15:545-554
22. Chemes HE, Rey RA, Nistal M, Regadera J, Musse M, González- Peramato P, Serrano A 2008 Physiological androgen insensitivity of the fetal, neonatal, and early infantile testis is explained by the ontogeny of the androgen receptor expression in Sertoli cells. J Clin Endocrinol Metab 93:4408-4412
23. Rey RA, Musse M, Venara M, Chemes HE 2009 Ontogeny of the androgen receptor expression in the fetal and postnatal testis: its relevance on Sertoli cell maturation and the onset of adult spermatogenesis. Microsc Res Tech 72:787-795
24. Rey R, Lordereau-Richard I, Carel JC, Barbet P, Cate RL, Roger M, Chaussain JL, Josso N 1993 Anti-mullerian hormone and testosterone serum levels are inversely during normal and precocious pubertal development. J Clin Endocrinol Metab 77:1220-1226
25. Rey R, Mebarki F, Forest MG, Mowszowicz I, Cate RL, Morel Y, Chaussain JL, Josso N 1994 Anti-mullerian hormone in children with androgen insensitivity. J Clin Endocrinol Metab 79:960-964
26. Al-Attar L, Noël K, Dutertre M, Belville C, Forest MG, Burgoyne PS, Josso N, Rey R 1997 Hormonal and cellular regulation of Sertoli cell anti-Mullerian hormone production in the postnatal mouse. J Clin Invest 100:1335-1343
27. o F, Gompel A, Czernichow P, Josso N 1999 Evaluation of gonadal function in 107 intersex patients by means of serum antimullerian hormone measurement. J Clin Endocrinol Metab 84:627-631
28. Bergadá I, Milani C, Bedecarrás P, Andreone L, Ropelato MG, Gottlieb S, Bergadá C, Campo S, Rey RA 2006 Time course of the serum gonadotropin surge, inhibins, and anti-Mullerian hormone in normal newborn males during the first month of life. J Clin Endocrinol Metab 91:4092-4098
29. Baker ML, Hutson JM 1993 Serum levels of mullerian inhibiting substance in boys throughout puberty and in the first two years of life. J Clin Endocrinol Metab 76:245-247
30. Baker ML, Metcalfe SA, Hutson JM 1990 Serum levels of mullerian inhibiting substance in boys from birth to 18 years, as determined by enzyme immunoassay. J Clin Endocrinol Metab 70:11-15 (Pubitemid 120009783)
31. Hudson PL, Dougas I, Donahoe PK, Cate RL, Epstein J, Pepinsky RB, MacLaughlin DT 1990 An immunoassay to detect human mullerian inhibiting substance in males and females during normal development. J Clin Endocrinol Metab 70:16-22
32. Josso N, Legeai L, Forest MG, Chaussain JL, Brauner R 1990 An enzyme linked immunoassay for anti-mullerian hormone: anewtool for the evaluation of testicular function in infants and children. J Clin Endocrinol Metab 70:23-27
33. van Rooij IA, Broekmans FJ, te Velde ER, Fauser BC, Bancsi LF, de Jong FH, Themmen AP 2002 Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve. Hum Reprod 17:3065-3071
34. Gruijters MJ, Visser JA, Durlinger AL, Themmen AP 2003 Anti-Mullerian hormone and its role in ovarian function. Mol Cell Endocrinol 211:85-90
35. Fénichel P, Rey R, Poggioli S, Donzeau M, Chevallier D, Pointis G 1999 Anti-Mullerian hormone as a seminal marker for spermatogenesis in non-obstructive azoospermia. Hum Reprod 14:2020-2024
36. Zalata AA, Hassan AH, Nada HA, Bragais FM, Agarwal A, Mostafa T 2008 Follicle-stimulating hormone receptor polymorphism and seminal anti-Mullerian hormone in fertile and infertile men. Andrologia 40:392-397
37. Fujisawa M, Yamasaki T, Okada H, Kamidono S 2002 The significance of anti-Mullerian hormone concentration in seminal plasma for spermatogenesis. Hum Reprod 17:968-970
38. Al-Qahtani A, Muttukrishna S, Appasamy M, Johns J, Cranfield M, Visser JA, Themmen AP, Groome NP 2005 Development of a sensitive enzyme immunoassay for anti-Mullerian hormone and the evaluation of potential clinical applications in males and females. Clin Endocrinol (Oxf) 63:267-273
39. Mostafa T, Amer MK, Abdel-Malak G, Nsser TA, Zohdy W, Ashour S, El-Gayar D, Awad HH 2007 Seminal plasma anti-Mullerian hormone level correlates with semen parameters but does not predict success of testicular sperm extraction (TESE). Asian J Androl 9:265-270